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Developmental changes in angiotensin II receptor subtypes and AT1
receptor mRNA in rat kidney. The changes in angiotensin II receptor
subtypes, type 1 (AT1) and type 2 (AT2) binding, and AT1 mRNA levels
during development were studied in the rat kidney using autoradiographic
and in situ hybridization techniques. Autoradiographic analysis of 'I-
[Sart, Ile8]Ang II binding to slide-mounted kidney sections from 2 and 5
day-old rats discerned AT2 binding sites associated with advancing tubules
and ampullae of the ureteric bud, and in the metanephric mass in the
nephrogenic zone of the cortex. AT1 binding was present in the meta-
nephric mass and immature glomeruli on days 2, 5 and 7 after birth.
Differentiating and mature kidneys of 14-day, 21-day and 14-week old
adult rats had solely AT1 receptor binding over glomeruli in renal cortex
and in the inner stripe of the outer medulla. AT1 mRNA was expressed
discretely as early as 2 days of age in the immature glomeruli and in a
diffuse radiating pattern in the renal cortex. In the medulla, AT1 receptor
mRNA expression appeared discretely on day 7 and reached peak levels
on day 21 in the inner stripe of the outer medulla. The data indicate that
AT1 receptor mRNA is developmentally regulated in rat kidney and its
expression in the cortex precedes that of AT1 receptor ligand binding. The
temporal pattern of expression of binding for both receptor subtypes
suggests that while AT2 receptors may be involved in cell proliferation and
early differentiation of the nephron, AT1 receptors have a dual role, early
in nephron differentiation and later in development in renal function.
Angiotensin II (Ang II) has multiple actions in the kidney,
including regulation of blood flow, glomerular filtration, tubular
reabsorption of electrolytes, and feedback inhibition of renin
secretion in the juxtaglomerular apparatus [1—5]. In addition, in
several systems, Ang II stimulates cell growth, expression of
growth factors, and growth-related proto-oncogenes [6—11]. The
biological effects of Ang II are mediated by specific receptors
located in the plasma membrane of the target tissues [12]. Ang II
receptor content undergoes dramatic changes during develop-
ment. For example, during late gestation in the fetus there are
abundant Ang II receptors widely distributed in skin, connective
tissue and skeletal muscle, which rapidly decline after birth
[13—17]. Increased Ang II receptor levels are also observed at
critical times during postnatal development in organs such as the
brain, adrenal and smooth muscle [17—19]. Two Ang II receptor
subtypes, AT1 and AT2, have been pharmacologically character-
ized using peptide and nonpeptide Ang II receptor antagonists
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[20]. Molecular cloning techniques have made possible the eluci-
dation of the molecular structure of the receptor subtypes, with
both sequences suggesting the presence of seven transmembrane
domains, characteristic of the G protein coupled receptors [21—
24]. While AT1 receptors are coupled to calcium-phospholipid
signaling systems and appear to mediate the known actions of Mg
II, the mechanism of action and physiological effects of AT2
receptors remains to be elucidated [17, 25].
In the kidney of adult primate and rat, in vitro autoradiographic
binding studies have shown that predominantly AT1 receptors are
present in the glomeruli, proximal tubules, inner stripe of the
outer medulla, and vasa recta bundles [26—29]. Ang II receptors,
with a significant proportion of AT2 receptors, are abundant and
widely distributed in primate and rodent fetal kidneys [15, 30—32].
In the rat, the kidney undergoes marked functional and struc-
tural changes during postnatal development [33—36]. In this
regard, the neonatal kidney does not concentrate urine as effi-
ciently and renal blood flow and glomerular filtration rate are
lower than in the adult kidney. Only a small proportion of
glomeruli is functional at birth and nephrogenesis is not com-
pleted until about 10 days of age. Ang II has been implicated in
growth and differentiation in the kidney. For example, Mg II acts
as a mitogen and stimulates the expression of extracellular matrix
proteins in cultured mesangial cells, effects which are mediated by
AT1 receptors [11, 37, 38]. Also, Aug II appears to be involved in
angiogenesis during glomerular differentiation in developing rats[39, 40]. To further understand the role of Ang II in renal
maturation, the developmental changes in expression of Ang II
receptor subtypes were studied in the kidney in rats at different
stages of postnatal development.
Methods
Animals and tissue preparation
Sprague-Dawley litters 1, 4, 6, 13 and 20 days of age, and 14-
week (adult) male rats (Zivic-Miller Laboratories Inc., Ze-
lienople, Pennsylvania, USA) were killed by decapitation and the
kidneys immediately removed and frozen in isopentane on dry ice
for binding autoradiography and in situ hybridization studies.
Consecutive sagittal sections (12 tm thick) of 2, 5, 7, 10, 14, 21
day-old, and 14 week-old rat kidney were cut on a cryostat at
—18°C and thaw-mounted onto gelatin/chrome alum double-
coated glass slides. Sections were dried in a desiccator at 4°C
under vacuum overnight for binding studies, or stored at —70°C
for in situ hybridization.
973
974 Aguilera et a!: Ang Ii receptor subtypes in rat kidney
In vitro binding. Binding of 1251-[Sar',11e8]Ang II to slide-
mounted tissue sections was performed as previously described
[41]. Sequential kidney sections were preincubated for 15 minutes
at 20°C in 10 m sodium phosphate buffer (pH 7.4) containing 5
mM EGTA, 0.1 mM bacitracin, 0.2% bovine serum albumin, 120
mM NaCI followed by 60 minutes incubation with 150 M
[Sar',Ile8JAng II in the presence or absence of 1 iM Ang II for
nonspecific binding. Ang II receptor subtypes were measured in
consecutive sections incubated with 1251-[Sar1,11e8]Ang II in the
presence of 10 tM concentrations of the heterologous antagonist,
DuP753 (Losartan) for AT2, and PD123177 for AT1. After
incubation, slides were washed four times for one minute, in
ice-cold 50 mM Tris buffer, pH 7.4, and dried under cool air.
Autoradiographic images were generated by exposing the dried
slides and brain paste standards to Hyperfilm-3H in x-ray cassettes
for three days and analyzed as described for in situ hybridization.
In situ hybridization. PCR fragments of 821 bp were generated
from rat liver RNA with primers based on sequences 282 through
310 upstream and 1075 through 1103 downstream from the coding
region of the rat kidney AT1 receptor [42], using reverse tran-
scriptase and polymerase (GeneAmp, Perkin Elmer, Norwalk,
Connecticut, USA). Poly-A RNA from rat liver was prepared
using Fast-Track (InVitrogen, San Diego, California, USA). The
cDNA fragment obtained by PCR was cloned into the EcoRI site
of pGEM-7Zf(--) and used for preparation of radiolabeled
probes. Restriction analysis and partial sequencing of the 820 bp
PCR fragment were consistent with the sequence of AT1 receptor
eDNA.
High specific activity sense and antisense probes were synthe-
sized in 10 il of 40 m'vi Tris-HC1, pH 7.5 containing 200 Ci each
of [35S]-UTP and [35S]-CTP (Amersham, Arlington Heights,
Illinois, USA), 4.8 m each of unlabeled ATP and GTP, 0.24 m
each of unlabeled UTP and CTP, 10 mM dithiothreitol, 6 mM
MgCI2, 2 mM spermidine, 10 mM NaCI, 15 U RNAsin, 1 j.g
linearized template, and 15 U of the appropriate RNA poly-
merase (SP6 for cRNA, and T7 for sense RNA). After 60 minutes
incubation at 42°C, the cDNA template was digested with
DNase-1 for 10 minutes at 37°C. Radiolabeled RNA products
were purified using quick spin columns (Boehringer Mannheim,
Indianapolis, Indiana, USA), precipitated with ethanol and resus-
pended in 50 p1 of 10 mrvi Tris HCI, pH 7.5, containing 20 mM
DT'F. The average specific activity of the probes was 2—3 x 108
dpm/tg. Unless otherwise specified, enzymes, and all molecular
biology reagents, were obtained from Promega (Madison, Wis-
consin, USA).
In situ hybridization was performed with slight modifications of
previously described procedures [14]. Sections were fixed in 4%
formaldehyde, acetylated, and then covered with 50 to 80 p1 of
hybridization buffer containing [35S]-labeled RNA probe (108
cpm/ml), 50 mr Tris HC1 buffer, pH 7.5, 50% formamide, 200 mM
NaCI, 2.5 mM EDTA, 10% dextran sulfate, 250 g/ml yeast tRNA,
50 mM dithiothreitol and 1 X Denhardt's solution. Slides were
covered with coverslips and incubated for 18 to 24 hours at 54°C in
humidified chambers. After hybridization, coverslips were removed
and sections subjected to consecutive washes in 4x SSC and 50%
formamide/300 nmt NaCI at 60°C, and then treated with RNase-A
(20 g/ml for 30 mm at 37°C), washed, dehydrated and exposed to
Hyperfilm-beta Max (Amersham) for 14 to 21 days. Tissue sections
were exposed together with a set of standards prepared by homoge-
neously mixing different amounts of [35S}dATP into aliquots of brain
paste (500 to 106 dpm/g). Individual standards were frozen in 0.5 ml
microfuge tubes, mounted together in embedding medium and 12
jm csyostat sections containing eight standards were thawed
mounted on glass. Light transmittance of the autoradiographic image
of the standards was plotted against dpm/mg corrected for radioac-
tive decay. Densities of the staining in the tissue were always within
the calibration curve, allowing for extrapolation of dpmlmg of probe
hybridized [43].
Levels of mRNA or binding were evaluated in autoradiographic
images from two to three sections from three rats of each age,
using a computerized image analysis system (Imaging Research
mc, Ontario Canada). For defined structures, such as kidney
glomeruli, five to 12 measurements were performed per section.
Results
Developmental changes in Ang II receptor binding
Total binding. Two days afterbirth, binding of 1251-[Sar',Ile]Ang
II was relatively homogeneous in renal cortex. Binding was more
prominent in the boundaiy between the cortex and the medulla
(juxtamedullary border). By day 7, high density binding with a
punctate pattern was present at sites corresponding to developing
nephrons (comma and S-shaped structures and immature glomer-
uli). The number of glomerular structures increased in number at
14 and 21 days to become homogeneously distributed throughout
the cortex in the now mature glomeruli, resulting in a progressive
increase in binding density in the total cortical area (Figs. 1 and 2).
Binding density in the glomeruli reached peak levels on day 21, In
the adult, binding density in the total cortical area/square unit
decreased, mainly due to increase in size of the interglomerular
tissue. However, no significant difference in binding density was
observed between glomeruli at day 21 and adult (Figs. 1 and 2).
Total binding in the medulla which was of moderate intensity at
two days, decreased at seven days and then increased again at 14
days reaching peak levels at day 21. In the adult, binding density
in the total medullary area was lower than at 21 days, but high
density binding remained confined to radiating longitudinal bands
in the inner stripe of the outer medulla (Figs. 1 and 2).
Ang II receptor subtypes. In the presence of Mg II receptor
subtype specific antagonists, autoradiographic analysis of the
binding revealed converse changes in the content of AT1 and AT2
receptors during nephrogenesis, with a progressive increase in
AT1 and a decrease in AT2 receptors (Figs. 1 and 2). At two days,
low density AT1 receptor binding was found diffusely distributed
throughout the cortex and medulla (Fig. 2). Overlying the diffuse
binding, a punctate pattern corresponding to developing glomer-
uli was observed in the cortex, with binding densities of 6.3 0.1
and 8.4 0.4 dpm/g, for interglomerular space and developing
glomeruli, respectively. The binding density of the glomeruli was
higher in the juxtamedullary area (12.2 0.4 dpm/g). AT1
binding in the general cortical area increased at five and seven
days, mainly due to the increase in number and binding intensity
of labeled areas over developing glomeruli (10.5 0.7 and 12.2
1.1 dpm/g at 5 and 7 days, respectively). The number of labeled
glomeruli per surface area and the binding density continue to
increase up to 21 days (13.1 0.6, 14.5 0.9 and 16.3 0.3
dpm/mg at 10, 14 and 21 days, respectively). Glomerular AT1
receptor binding remained at the same levels in the adult (16.7
1.3), but the number of glomeruli per area decreased due to an
increase in size of the interglomerular area.
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Fig. 1. Changes in Ang II receptors in the total renal cortex (A) and renal
medulla (B) areas during postnatal development in the rat, measured by
autoradiography. Total binding (•) was measured in presence of the
radioactive ligand alone, AT2 receptors (A) in presence of 1 xM of the
AT1 antagonist, Losartan, and AT1 receptors (U) in the presence of 1 xM
the AT2 antagonist, PD123177. Data points are the mean of optical
density values obtained in 8 to 12 kidney sections from 3 experiments.
In the renal medulla of two day-old rats, relatively high AT1
receptor binding density (10.5 0.5 dpmlj.xg), with a radiating
pattern was confined to a narrow area between the cortical and
medullary regions. This radiating strip of AT1 receptor binding in
the juxtamedullary border was more marked at seven days (12.4
0.3 dpm/xg) and the labeled area extended progressively to the
whole inner stripe of the outer medulla at later ages. In conjunc-
tion with the increase in area, there was a progressive increase in
binding density (13.7 0.4 and 15.8 0.5 dpm/jxg at 10 and 14
days), which reached a maximum at 21 days (17.6 0.6 dpm/xg)
and declined in the adult (15.4 0.5 dpm/mg), where areas of
very high density AT1 binding (17.5 0.7 dpm/rg) were confined
to radiating longitudinal bands overlying an area of moderate
labeling (14.3 0.2 dpm/jxg). In the inner medulla AT1 receptor
binding was confined to a narrow line of high density binding at
the border of the papilla.
In contrast to the AT1 receptor binding, AT2 receptor binding
declined progressively during development. Moderate AT2 recep-
tor binding (15.6 0.6 dpm/xg) in the cortex at two days was
distributed in a defined radiating pattern, beginning at the jux-
tamedullary region and extending to the subcapsular region. In
close association with this binding, additional AT2 binding of
similar density (16.8 0.6 dpm/xg) was present in a knot-like
fashion in the metanephric mesenchyme of the future nephrons in
the subcapsular cortex. The density of this binding decreased at
five and seven days (8.8 0.3 and 5.4 0.6 dpm/xg, respectively),
becoming undetectable at day 14. Two days after birth moderate
levels of AT2 binding were present in the medulla (14.2 0.7
dpm/jxg), gradually decreasing at five and seven days (9.6 and 6.2
dpm/xg, respectively), becoming undetectable on day 14 (Figs. 1
and 2).
Developmental changes in AT1 receptor mRNA
In contrast to the gradual increase in AT1 receptor binding
levels in the kidney cortex from low levels at day 2 to adult levels
at day 21, in situ hybridization studies revealed the presence of
AT1 receptor mRNA with a punctate pattern in the cortex of two
day-old rats with an intensity similar to that at 21 days (Fig. 3). In
addition to this punctate hybridization in the cortex, there was a
radiating pattern overlayed with diffuse hybridization. While this
radiating pattern of AT1 mRNA was still present in the cortex at
21 days, in the adult kidney it was mostly confined to the outer
zone of the outer medulla (Fig. 3). In glomeruli, hybridization
levels were similar from two to 21 days (2.5 0.1, 2.2 0.1, 2.2
0.1, 1.8 0.2, 2.2 0.1 and 2.2 0.1 dpm/xg at 2,5, 7, 10, 14
and 21 days, respectively), and decreased to 0.95 0.01 dpm/jxg
in the adult.
Very low hybridization was present in the renal medulla of two
and five day-old rats. However, higher levels of hybridization with
a bidirectional radiating pattern were observed in a narrow band
confined to the juxtamedullary border. As shown in Figure 3,
hybridization levels in this area increased markedly after day 2,
exhibiting a progressive extension towards a broad inner band of
the outer medulla and reaching peak levels on day 21 of devel-
opment (2.4 0.1, 3.4 0.1, 3.0 0.2 and 5.0 0.1 at 7, 10, 14
and 21 days, respectively). In the adult renal medulla, hybridiza-
tion levels remained high in the inner stripe of the outer medulla,
where radiating bands of high density (2.7 0.1 dpm//Lg)
overlayed an area of diffuse moderate intensity labeling (1.3 0.1
dpm/xg). On the other hand, hybridization levels in the outer
stripe of the outer medulla were reduced compared with the levels
at 14 and 21 days and were restricted to a radiating pattern (2.3
0.1, 2.6 0.1 and 0.8 0.01 dpm//Lg at 14, 21 and adult,
respectively). Minimal levels of diffuse hybridization with a radi-
ating pattern were found in the outer portion of the inner
medulla. Expression of mRNA for AT1 was undetectable in the
inner portion of the inner medulla, except at the medullary papilla
border which extends into the renal pelvis (Fig. 3).
Discussion
These studies show prominent changes in expression of Ang II
receptor subtypes during postnatal kidney development, with
progressive increases in AT1 receptors and decreases in AT2
receptor binding. In the rat kidney, the full complement of
developing nephrons is achieved by four to five days of age [361,
but their maturation is not completed until the third week after
birth. In the present experiments, a well-defined punctate pattern
of AT1 receptor binding corresponding to glomeruli was not
apparent until seven days and reached a homogeneous adult
pattern only 14 to 21 days after birth in parallel with nephron
maturation. However, in contrast to the report by Ciuffo et at,
which show AT1 receptors exclusively located in mature glomeruli
[32j, the present experiments demonstrate low levels of AT1
receptor binding clearly associated with developing glomeruli in
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Fig. 2. Autoradiography of totalAng II receptors (radioactive ligand alone), AT2 receptors (after blockade ofAT2 with 10 p.MPD 123177), andAT2 receptors
(after blockade ofAT3 receptors with 10 pu Losartan) in rat kidney at different stages of postnatal development. Abbreviations are: c, cortex; g, glomeruli;
im, inner medulla; is, inner stripe of the outer medulla; jmb, juxtamedullary border; jmg, juxtamedullary glomeruli; os, outer stripe of the outer medulla.
The Figure is representative of the results in three binding experiments.
the renal cortex of two day-old rats. Consistent with the presence the present experiments and the finding of AT1 receptor mRNA
of AT1 receptors during early nephrogenesis in the cortex are the in the nephrogenic zone of the renal cortex in newborn rats [44].
high levels of AT1 receptor mRNA located in S-shaped bodies in It should be noted that AT1 receptor mRNA hybridization to
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Fig. 3. In situ hybridization ofAT1 receptor mRIVA in sections from kidneys of rats at different stages of postnatal development. Abbreviations used are as
in Figure 2.
preglomeruli and glomeruli is higher at early ages than in the
adult and is sustained at high levels throughout the period of
glomerular development. The lag between the expression of
mRNA and ligand binding may reflect inefficient post-transcrip-
tional processing of the mRNA. It is also possible that high AT1
receptor turnover associated with increased exposure to Ang II
may contribute to the low binding levels at early ages. In this
regard, it has been shown that the activity of the renin-angiotensin
system is higher in the neonate than in adult rats {34, 45— 471. The
demonstration of AT1 receptors in developing nephrons supports
the view that this receptor subtype has a role during differentia-
tion and maturation of the nephron.
In contrast to the abundance of AT1 receptor mRNA in the
renal cortex of neonatal rats, levels were very low in the medulla
and increased progressively after seven days in parallel with AT1
receptor binding. This suggests that the major role of Ang II in the
kidney medulla relates to functional aspects of the mature
nephron rather than to differentiation and growth. In general, the
978 Aguilera et at: Ang II receptor subtypes in rat kidney
distribution of AT1 receptor mRNA in the adult kidney is in
agreement with the known distribution of AT1 receptor binding
and the physiological effects of Ang II in the kidney [28,29].
In contrast to the progressive increase in AT1 receptor expres-
sion during development, AT2 receptor binding decreased from
birth to become undetectable after differentiation has been com-
pleted. High levels of AT2 binding have also been reported in
cortical and medullary regions of the fetal human kidney [31], and
in immature glomeruli (S-shaped bodies) of neonatal rats [32].
A significant finding in the present study is the pattern of
expression of AT2 receptors in the kidney at early ages. The
discrete distribution and time of expression of the binding is
consistent with the location of these receptors in the ampullae and
advancing tubules of the ureteric bud in the cortex, and in the
associated subcapsular metanephric mass early in development
[35, 48, 49]. Since differentiation of the proper nephron from
the metanephric mass is dependent on the inductive role of the
ureteric ampullae at the distal end of the ureteric tubules in the
cortex, the presence of AT2 receptors at this early stage suggests
a critical role for this receptor during the growth phase of
nephrogenesis. Similarly, the temporal pattern of expression of
AT2 receptors in the medulla is consistent with a role in prolifer-
ation and formation of collecting tubules and in the development
of renal calices and pelvis.
Increasing evidence indicates that Ang II can influence growth
in the kidney. Ang II has been implicated in angiogenesis during
glomerular differentiation [40], and it has been shown that
converting enzyme inhibitors retard glomerular growth [50]. Also,
in mesangial cells in culture, Ang II stimulates cell proliferation
and increases the secretion of the extracellular matrix protein,
fibronectin, and fibronectin mRNA levels [11, 37, 38]. Although
the abundant AT2 receptors expressed during early development
may have a role in these processes, all the recognized effects of
Ang II on cell growth in the kidney and other systems appear to
be mediated primarily by AT1, and not by AT2 receptors [17, 38,
51]. A similar temporal relationship between AT2 receptor ex-
pression and tissue differentiation has been observed in a number
of neural pathways in the central nervous system, where areas of
high AT2 receptor concentration are found at the time of maximal
synaptogenic activity [18].
Although the exact role of AT2 receptors remains to be
elucidated, their pattern of expression at critical times of nephro-
genesis strongly suggests a role for this Ang II receptor subtype in
kidney growth and differentiation. On the other hand, the pro-
gressive increase in expression of AT1 receptor binding during the
differentiation stages of nephrogenesis, with peak levels in the
mature kidney, is consistent with a dual role of this receptor, first,
in nephron differentiation after the inductive influence of the
ureteric bud, and later in kidney function.
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